| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.493 | 0.011 | 0.493 | RNA-directed DNA polymerase inhibitor | 0.433 0.015 CID_468304 0.385 0.02 CID_154700087 | ||
| 0.471 | 0.018 | 0.515 | Cardiotonic | 0.497 0.015 CID_468304 0.515 0.014 CID_154700087 | CID_154700087 | |
| 0.45 | 0.004 | 0.45 | Vanilloid antagonist | 0.37 0.005 CID_468304 0.16 0.019 CID_154700087 | ||
| 0.349 | 0.006 | 0.349 | Focal adhesion kinase 2 inhibitor | 0.328 0.009 CID_468304 0.315 0.011 CID_154700087 | ||
| 0.281 | 0.079 | 0.281 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.228 0.127 CID_468304 0.228 0.128 CID_154700087 | ||
| 0.204 | 0.005 | 0.345 | NMDA 2B receptor antagonist | 0.345 0.004 CID_468304 0.201 0.005 CID_154700087 | CID_468304 | |
| 0.199 | 0.01 | 0.222 | Vanilloid 1 antagonist | 0.222 0.008 CID_468304 0.12 0.02 CID_154700087 | CID_468304 | |
| 0.193 | 0.008 | 0.193 | Adrenaline agonist | 0.17 0.01 CID_468304 0.192 0.008 CID_154700087 | ||
| 0.195 | 0.01 | 0.195 | HIV-1 reverse transcriptase inhibitor | 0.137 0.017 CID_468304 0.157 0.013 CID_154700087 | ||
| 0.17 | 0.012 | 0.285 | Rho-associated kinase I inhibitor | 0.285 0.005 CID_468304 | CID_468304 | |
| 0.181 | 0.023 | 0.207 | MAP kinase kinase 4 inhibitor | 0.207 0.011 CID_468304 0.163 0.041 CID_154700087 | CID_468304 | |
| 0.212 | 0.068 | 0.212 | Death-associated protein kinase 3 inhibitor | 0.192 0.079 CID_468304 | ||
| 0.139 | 0.005 | 0.169 | Dopamine D3 agonist | 0.169 0.004 CID_468304 0.125 0.005 CID_154700087 | CID_468304 | |
| 0.135 | 0.011 | 0.158 | Alpha 1 adrenoreceptor agonist | 0.158 0.009 CID_468304 | CID_468304 | |
| 0.137 | 0.018 | 0.155 | Alpha adrenoreceptor agonist | 0.155 0.015 CID_468304 | CID_468304 | |
| 0.159 | 0.041 | 0.159 | Aurora-C kinase inhibitor | 0.135 0.074 CID_468304 0.127 0.09 CID_154700087 | ||
| 0.131 | 0.018 | 0.131 | Syk tyrosine kinase inhibitor | 0.099 0.029 CID_468304 | ||
| 0.113 | 0.01 | 0.145 | Bromodomain-containing protein 4 inhibitor | 0.145 0.007 CID_468304 0.143 0.007 CID_154700087 | CID_468304 | |
| 0.126 | 0.025 | 0.126 | Janus tyrosine kinase 3 inhibitor | 0.115 0.027 CID_468304 0.073 0.05 CID_154700087 | ||
| 0.269 | 0.168 | 0.373 | MAP kinase kinase 6 inhibitor | 0.373 0.076 CID_468304 | CID_468304 | |
| 0.135 | 0.039 | 0.149 | Cyclin-dependent kinase 9 inhibitor | 0.149 0.034 CID_468304 | CID_468304 | |
| 0.117 | 0.025 | 0.389 | NMDA 2 receptor antagonist | 0.389 0.004 CID_468304 0.174 0.012 CID_154700087 | CID_468304 | |
| 0.112 | 0.022 | 0.112 | Focal adhesion kinase 1 inhibitor | 0.081 0.049 CID_468304 0.098 0.032 CID_154700087 | ||
| 0.163 | 0.075 | 0.163 | Heat shock protein 90 alpha antagonist | 0.158 0.079 CID_468304 | ||
| 0.168 | 0.082 | 0.186 | LIM domain kinase 1 inhibitor | 0.186 0.07 CID_468304 0.127 0.126 CID_154700087 | CID_468304 | |
| 0.116 | 0.033 | 0.116 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.155 | 0.074 | 0.167 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.167 0.067 CID_468304 0.121 0.1 CID_154700087 | CID_468304 | |
| 0.103 | 0.026 | 0.103 | Tyk2 inhibitor | 0.063 0.046 CID_154700087 | ||
| 0.295 | 0.22 | 0.295 | Antiinflammatory | |||
| 0.079 | 0.004 | 0.079 | Vanilloid 4 antagonist | 0.044 0.009 CID_468304 0.059 0.005 CID_154700087 | ||
| 0.172 | 0.099 | 0.173 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.173 0.098 CID_468304 | CID_468304 | |
| 0.227 | 0.154 | 0.227 | Sodium/bile acid cotransporter inhibitor | |||
| 0.147 | 0.077 | 0.173 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.173 0.039 CID_468304 | CID_468304 | |
| 0.105 | 0.037 | 0.105 | Neuropeptide Y antagonist | 0.087 0.049 CID_468304 0.075 0.067 CID_154700087 | ||
| 0.093 | 0.027 | 0.093 | MAP3K7 inhibitor | 0.067 0.059 CID_468304 | ||
| 0.129 | 0.066 | 0.205 | Glutamate receptor antagonist | 0.205 0.024 CID_468304 | CID_468304 | |
| 0.073 | 0.01 | 0.083 | Alpha 1b adrenoreceptor agonist | 0.083 0.007 CID_468304 0.062 0.018 CID_154700087 | CID_468304 | |
| 0.099 | 0.036 | 0.099 | Janus tyrosine kinase 2 inhibitor | 0.092 0.04 CID_468304 | ||
| 0.116 | 0.06 | 0.116 | CDK3/cyclin E inhibitor | 0.101 0.085 CID_154700087 | ||
| 0.093 | 0.042 | 0.101 | Glutamate receptor agonist | 0.101 0.037 CID_468304 | CID_468304 | |
| 0.055 | 0.007 | 0.055 | AMPA receptor agonist | 0.049 0.009 CID_468304 0.05 0.009 CID_154700087 | ||
| 0.064 | 0.019 | 0.088 | Dopamine D2 agonist | 0.084 0.013 CID_468304 0.088 0.013 CID_154700087 | CID_154700087 | |
| 0.099 | 0.058 | 0.099 | DNA directed RNA polymerase inhibitor | 0.086 0.075 CID_468304 0.084 0.078 CID_154700087 | ||
| 0.136 | 0.095 | 0.201 | Cyclin-dependent kinase 8 inhibitor | 0.201 0.035 CID_468304 | CID_468304 | |
| 0.077 | 0.038 | 0.078 | Elastase 1 inhibitor | 0.075 0.041 CID_468304 0.078 0.037 CID_154700087 | CID_154700087 | |
| 0.108 | 0.07 | 0.111 | Activin receptor-like kinase 4 inhibitor | 0.111 0.064 CID_468304 | CID_468304 | |
| 0.091 | 0.055 | 0.091 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.059 | 0.023 | 0.061 | Vanilloid 2 antagonist | 0.061 0.021 CID_468304 0.058 0.025 CID_154700087 | CID_468304 | |
| 0.058 | 0.022 | 0.064 | Mineralocorticoid receptor antagonist | 0.064 0.017 CID_468304 0.06 0.02 CID_154700087 | CID_468304 | |
| 0.121 | 0.086 | 0.121 | Tyrosine-protein kinase receptor antagonist | 0.108 0.099 CID_468304 | ||
| 0.1 | 0.065 | 0.109 | Folate antagonist | 0.109 0.05 CID_468304 | CID_468304 | |
| 0.189 | 0.158 | 0.245 | MAP kinase kinase 3 inhibitor | 0.245 0.036 CID_468304 | CID_468304 | |
| 0.038 | 0.008 | 0.047 | Alpha 1a adrenoreceptor agonist | 0.047 0.005 CID_468304 0.026 0.013 CID_154700087 | CID_468304 | |
| 0.218 | 0.188 | 0.218 | Antiobesity | 0.208 0.199 CID_468304 | ||
| 0.15 | 0.121 | 0.251 | MAP kinase kinase 2 inhibitor | 0.251 0.054 CID_468304 | CID_468304 | |
| 0.054 | 0.025 | 0.071 | Histamine H4 receptor antagonist | 0.071 0.012 CID_468304 | CID_468304 | |
| 0.068 | 0.041 | 0.07 | Beta adrenoreceptor antagonist | 0.07 0.039 CID_154700087 | CID_154700087 | |
| 0.144 | 0.12 | 0.149 | Death-associated protein kinase 2 inhibitor | 0.149 0.108 CID_468304 | CID_468304 | |
| 0.057 | 0.032 | 0.06 | Phosphatidylinositol 3-kinase alpha inhibitor | 0.06 0.03 CID_468304 | CID_468304 | |
| 0.116 | 0.094 | 0.116 | Cytokine production inhibitor | |||
| 0.047 | 0.026 | 0.054 | Beta adrenoreceptor agonist | 0.044 0.034 CID_468304 0.054 0.012 CID_154700087 | CID_154700087 | |
| 0.06 | 0.041 | 0.06 | Bcl-xL inhibitor | 0.06 0.039 CID_154700087 | ||
| 0.043 | 0.028 | 0.046 | Alpha 1L adrenoreceptor agonist | 0.046 0.023 CID_468304 0.043 0.028 CID_154700087 | CID_468304 | |
| 0.058 | 0.043 | 0.106 | Phosphatidylinositol kinase inhibitor | 0.106 0.019 CID_468304 | CID_468304 | |
| 0.096 | 0.082 | 0.096 | Polo-like kinase-4 inhibitor | |||
| 0.092 | 0.079 | 0.092 | Hedgehog signaling inhibitor | 0.091 0.084 CID_468304 | ||
| 0.05 | 0.038 | 0.058 | mTOR inhibitor | 0.058 0.03 CID_468304 | CID_468304 | |
| 0.054 | 0.042 | 0.076 | MAP kinase kinase 9 inhibitor | 0.076 0.017 CID_468304 | CID_468304 | |
| 0.046 | 0.036 | 0.059 | Aldosterone antagonist | 0.059 0.02 CID_468304 0.05 0.03 CID_154700087 | CID_468304 | |
| 0.061 | 0.052 | 0.074 | Beta 3 adrenoreceptor antagonist | 0.074 0.028 CID_154700087 | CID_154700087 | |
| 0.052 | 0.042 | 0.053 | CC chemokine 2 receptor antagonist | 0.049 0.047 CID_468304 0.053 0.04 CID_154700087 | CID_154700087 | |
| 0.079 | 0.069 | 0.109 | Adrenaline antagonist | 0.109 0.049 CID_468304 0.075 0.073 CID_154700087 | CID_468304 | |
| 0.08 | 0.071 | 0.11 | Antiadrenergic | 0.11 0.05 CID_468304 0.077 0.074 CID_154700087 | CID_468304 | |
| 0.118 | 0.11 | 0.118 | Tyrosine kinase inhibitor | 0.116 0.112 CID_468304 | ||
| 0.136 | 0.129 | 0.136 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.135 0.13 CID_468304 | ||
| 0.193 | 0.188 | 0.193 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.097 | 0.093 | 0.097 | TRKA antagonist | 0.096 0.095 CID_468304 | ||
| 0.045 | 0.041 | 0.101 | Phosphatidylinositol 3-kinase beta inhibitor | 0.101 0.012 CID_468304 | CID_468304 | |
| 0.005 | 0.003 | 0.005 | Reverse transcriptase (HBV) inhibitor | |||
| 0.01 | 0.009 | 0.01 | Beta 3 adrenoreceptor agonist | |||
| 0.026 | 0.026 | 0.03 | Glucocorticoid antagonist | 0.03 0.024 CID_468304 | CID_468304 | |
| 0.061 | 0.062 | 0.093 | I kappa B kinase 1 inhibitor | 0.093 0.026 CID_468304 | CID_468304 | |
| 0.143 | 0.146 | 0.164 | Aldehyde oxidase inhibitor | 0.164 0.127 CID_154700087 | CID_154700087 | |
| 0.047 | 0.05 | 0.058 | Phosphatidylinositol 3-kinase delta inhibitor | 0.058 0.039 CID_468304 | CID_468304 | |
| 0.073 | 0.077 | 0.082 | MAP kinase 7 inhibitor | 0.082 0.037 CID_468304 | CID_468304 | |
| 0.1 | 0.104 | 0.124 | Cyclooxygenase 2 inhibitor | 0.124 0.075 CID_468304 | CID_468304 | |
| 0.061 | 0.066 | 0.089 | Rho-associated kinase inhibitor | 0.089 0.04 CID_468304 | CID_468304 | |
| 0.052 | 0.06 | 0.076 | Dopamine agonist | 0.076 0.039 CID_468304 | CID_468304 | |
| 0.053 | 0.067 | 0.083 | Alpha 1b adrenoreceptor antagonist | 0.083 0.044 CID_468304 | CID_468304 | |
| 0.066 | 0.082 | 0.079 | Bcr-Abl kinase inhibitor | 0.079 0.066 CID_468304 | CID_468304 | |
| 0.085 | 0.102 | 0.101 | mTOR complex 1 inhibitor | 0.101 0.059 CID_468304 | CID_468304 | |
| 0.088 | 0.11 | 0.136 | MAP kinase kinase inhibitor | 0.136 0.06 CID_468304 | CID_468304 | |
| 0.039 | 0.062 | 0.08 | Alpha 1d adrenoreceptor antagonist | 0.08 0.03 CID_468304 | CID_468304 | |
| 0.044 | 0.07 | 0.062 | p38 MAP kinase inhibitor | 0.062 0.05 CID_154700087 | CID_154700087 | |
| 0.063 | 0.093 | 0.214 | NMDA receptor antagonist | 0.214 0.012 CID_468304 0.091 0.053 CID_154700087 | CID_468304 | |
| 0.021 | 0.05 | 0.029 | 5 Hydroxytryptamine 6 agonist | 0.029 0.019 CID_468304 | CID_468304 | |
| 0.097 | 0.143 | 0.161 | Diuretic | 0.161 0.068 CID_468304 | CID_468304 | |
| 0.05 | 0.1 | 0.079 | Alpha 2a adrenoreceptor antagonist | 0.079 0.049 CID_468304 | CID_468304 | |
| 0.113 | 0.167 | 0.151 | Antipruritic | 0.151 0.093 CID_468304 | CID_468304 | |
| 0.05 | 0.113 | 0.065 | Beta 2 adrenoreceptor agonist | 0.065 0.032 CID_154700087 | CID_154700087 | |
| 0.085 | 0.15 | 0.122 | Cyclooxygenase inhibitor | 0.122 0.097 CID_468304 | CID_468304 | |
| 0.086 | 0.154 | 0.132 | Activin receptor-like kinase 2 inhibitor | 0.132 0.083 CID_468304 | CID_468304 | |
| 0.069 | 0.14 | 0.129 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.129 0.075 CID_468304 | CID_468304 | |
| 0.051 | 0.13 | 0.082 | MAP-kinase-activated kinase inhibitor | 0.082 0.06 CID_468304 | CID_468304 | |
| 0.044 | 0.125 | 0.071 | MAP-kinase-activated kinase 2 inhibitor | 0.071 0.057 CID_468304 | CID_468304 | |
| 0.064 | 0.154 | 0.08 | Transforming growth factor beta 3 antagonist | 0.08 0.064 CID_468304 | CID_468304 | |
| 0.037 | 0.13 | 0.076 | I kappa B kinase 2 inhibitor | 0.076 0.026 CID_468304 | CID_468304 | |
| 0.021 | 0.114 | 0.048 | Bromodomain-containing protein 3 inhibitor | 0.048 0.037 CID_468304 | CID_468304 | |
| 0.044 | 0.138 | 0.075 | Alpha 2 adrenoreceptor antagonist | 0.075 0.073 CID_468304 | CID_468304 | |
| 0.017 | 0.114 | 0.061 | AMPA receptor antagonist | 0.061 0.024 CID_468304 | CID_468304 | |
| 0.039 | 0.153 | 0.082 | Alpha adrenoreceptor antagonist | 0.082 0.07 CID_468304 | CID_468304 | |
| 0.117 | 0.241 | 0.194 | 5 Hydroxytryptamine 1E antagonist | 0.194 0.138 CID_468304 | CID_468304 | |
| 0.102 | 0.23 | 0.158 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.158 0.117 CID_468304 | CID_468304 | |
| 0.039 | 0.172 | 0.092 | I kappa B kinase inhibitor | 0.092 0.046 CID_468304 | CID_468304 | |
| 0.061 | 0.209 | 0.121 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.121 0.115 CID_468304 | CID_468304 | |
| 0.115 | 0.266 | 0.162 | MAP-kinase-activated kinase 5 inhibitor | 0.162 0.161 CID_468304 | CID_468304 | |
| 0.007 | 0.781 | 0.098 | Nicotinic acid receptor 1 agonist | 0.098 0.008 CID_154700087 | CID_154700087 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |